LENSAR Inc reports results for the quarter ended December 31 - Earnings Summary

• LENSAR Inc LNSR.OQ reported a quarterly adjusted loss of $1.61​​ per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -35 cents. The mean expectation of two analysts for the quarter was for a loss of 18 cents per share. Wall Street expected results to range from -22 cents to -14 cents per share.

• Revenue rose 38.2% to $16.73 million from a year ago; analysts expected $14.90 million.

• LENSAR Inc's reported EPS for the quarter was a loss of $1.61​.

• The company reported a quarterly loss of $18.71 million.

• LENSAR Inc shares had risen by 5.9% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

Wall Street's median 12-month price target for LENSAR Inc is $13.00

This summary was machine generated from LSEG data February 27 at 05:37 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)